Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Pao

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2016
Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3Niels R Reinders, Yvonne Pao, Maria C Renner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2020
SYNPLA, a method to identify synapses displaying plasticity after learningKim Dore, Yvonne Pao, Jose Soria Lopez, et al.
Blood|July 18, 2013
An evolutionarily conserved program of B-cell development and activation in zebrafishDawne M Page, Valerie Wittamer, Julien Y Bertrand, et al.
Mabs|February 12, 2025
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular propertiesNilufer P Seth, Rui Xu, Matthew DuPrie, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2016
Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3Niels R Reinders, Yvonne Pao, Maria C Renner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2020
SYNPLA, a method to identify synapses displaying plasticity after learningKim Dore, Yvonne Pao, Jose Soria Lopez, et al.
Blood|July 18, 2013
An evolutionarily conserved program of B-cell development and activation in zebrafishDawne M Page, Valerie Wittamer, Julien Y Bertrand, et al.
Mabs|February 12, 2025
Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular propertiesNilufer P Seth, Rui Xu, Matthew DuPrie, et al.
Pageof 1